How can we improve the diagnosis and management of bladder pain syndrome? Part 2:ICI-RS 2018
| Autor: | Vik Khullar, Mohammad S. Rahnama'i, Roger R. Dmochowski, Arun Sahai, Tufan Tarcan, G. Alessandro Digesu, Christopher Chermansky, Nikolaus Veit-Rubin |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
medicine.medical_specialty
Bladder Pain Syndrome Urology 030232 urology & nephrology Cystitis Interstitial Conservative Treatment Pelvic Pain Painful Bladder Syndrome 03 medical and health sciences 0302 clinical medicine Intravesical instillation Medicine Humans Botulinum Toxins Type A Intensive care medicine 030219 obstetrics & reproductive medicine business.industry Invasive treatments Interstitial cystitis Disease Management medicine.disease Botulinum toxin Neuromodulation (medicine) Administration Intravesical Neurology (clinical) business Surgical interventions medicine.drug |
| Zdroj: | Neurourology and urodynamicsREFERENCES. 38 |
| ISSN: | 1520-6777 |
| Popis: | Background This paper summarises the discussion in a think tank at the International Consultation on Incontinence-Research Society (ICI-RS) 2018 about the treatment of bladder pain syndrome. Aims To review the treatments of bladder pain syndrome from behavioural treatments to surgical interventions. Materials and methods Review the literature in the light of the think tank discussions. Results All guidelines recommend different levels of treatment starting with conservative behavioral treatments then introducing oral treatments followed by intravesical instillations. If these treatments fail then more invasive treatments such as botulinum toxin injections, neuromodulation, or surgery could be suggested. Conclusion Unfortunately for all treatments, the numbers are limited and, therefore, the evidence base is not strong. Further suggestions for research are suggested. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text